Breaking News Instant updates and real-time market news.

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:45
04/23/18
04/23
17:45
04/23/18
17:45

Tivity Health falls 19% after Q1 revenue misses estimates

Shares of Tivity Health are down 18.9% in after-hours trading to $32 per share.

  • 23

    Apr

  • 12

    Jun

TVTY Tivity Health
$39.50

-0.6 (-1.50%)

02/23/18
BRRR
02/23/18
NO CHANGE
Target $47
BRRR
Outperform
Tivity Health price target raised to $47 from $40 at Barrington
Barrington analyst Michael Petusky raised his price target for Tivity Health to $47 saying the "big" upside in Q4 and "strong" 2018 guidance add to his conviction. The analyst believes "material upside remains" in the shares and keeps an Outperform rating on the name.
02/23/18
CANT
02/23/18
NO CHANGE
Target $53
CANT
Overweight
Tivity Health price target raised to $53 from $45 at Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper raised his price target for Tivity Health to $53 saying the company last night reported a "strong" Q4 and "solid" 2018 outlook. The company continues to benefit from strong growth across its three platforms: SilverSneakers, Prime Fitness and WholeHealth Living, Halper tells investors in a post-earnings research note. He reiterates an Overweight rating on the name.
11/07/17
BRRR
11/07/17
NO CHANGE
Target $40
BRRR
Outperform
Tivity Health price target lowered to $40 from $46 at Barrington
Barrington analyst Michael Petusky lowered his price target for Tivity Health (TVTY) to $40 after UnitedHealth (UNH), which represents about 15%-17% of Tivity's overall revenue, disclosed that it would be competing with the company's SilverSneakers program in 11 states as of January 1, 2018. Based on the analyst's conversation last night with management, he still suspects UnitedHealth will continue to be a material customer of Tivity through at least the end of the contract in 2020. Petusky cations, however, that he has no real clarity on how much additional business could transition to United's internal offering beyond 2018. He maintains an Outperform rating on Tivity Health.
11/06/17
OPCO
11/06/17
NO CHANGE
OPCO
Tivity Health oversold on UnitedHealth news, says Oppenheimer
Oppenheimer analyst Mohan Naidu views Tivity Health (TVTY) as oversold after UnitedHealth (UNH) said its Optum Fitness Advantage program will be available, at no additional cost, to Individual Medicare Advantage plans members in 11 states, starting January 2018. The analyst believes this is only for the individual market and that Tivity's SilverSneakers will be available for all group members. Further, he notes that Tivity management confirmed that their initial 2018 guidance already contemplates the impact of the UnitedHealth rollout. While it is possible that the Optum Fitness introduction is a precursor to a broader program, SilverSneaker's name and trust drives a lot of enrollment decisions and will likely be a deciding factor in the expansion of this new offering, Naidu tells investors in an intraday research note. Tivity Health is down 31%, or $14.70, to $33.35 in afternoon trading.

TODAY'S FREE FLY STORIES

TRXC

TransEnterix

$6.04

0.24 (4.14%)

15:25
09/18/18
09/18
15:25
09/18/18
15:25
Options
TransEnterix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

MB

Mindbody

$41.15

1.1 (2.75%)

15:25
09/18/18
09/18
15:25
09/18/18
15:25
Conference/Events
Mindbody to host analyst day »

Analyst day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/18/18
09/18
15:17
09/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/18/18
09/18
15:16
09/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGS

B&G Foods

$30.40

-1.15 (-3.65%)

15:10
09/18/18
09/18
15:10
09/18/18
15:10
Options
Bearish option flow in B & G Foods as shares drop 3.8% »

Bearish option flow in B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 06

    Nov

15:10
09/18/18
09/18
15:10
09/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

YELP

Yelp

$50.19

3.905 (8.44%)

15:05
09/18/18
09/18
15:05
09/18/18
15:05
Options
Yelp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$20.35

9.95 (95.67%)

14:58
09/18/18
09/18
14:58
09/18/18
14:58
Recommendations
Viking Therapeutics analyst commentary  »

Viking price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 01

    Oct

ACHV

Achieve Life Sciences

$2.55

-0.05 (-1.92%)

14:56
09/18/18
09/18
14:56
09/18/18
14:56
Conference/Events
Achieve Life Sciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$362.55

12.31 (3.51%)

, VIA

Viacom

$33.80

0.05 (0.15%)

14:52
09/18/18
09/18
14:52
09/18/18
14:52
Hot Stocks
Netflix working on live-action version of 'Avatar: The Last Airbender' »

Netflix (NFLX) confirmed…

NFLX

Netflix

$362.55

12.31 (3.51%)

VIA

Viacom

$33.80

0.05 (0.15%)

VIAB

Viacom

$30.26

0.2 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

BX

Blackstone

$37.63

0.53 (1.43%)

14:47
09/18/18
09/18
14:47
09/18/18
14:47
Conference/Events
Blackstone to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

ING

ING Group

$13.00

0.05 (0.39%)

14:46
09/18/18
09/18
14:46
09/18/18
14:46
Syndicate
Breaking Syndicate news story on ING Group »

ING Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNST

Constellation Pharmaceuticals

$7.01

-0.64 (-8.37%)

14:44
09/18/18
09/18
14:44
09/18/18
14:44
Conference/Events
Constellation Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 21

    Sep

NTDOY

Nintendo

$0.00

(0.00%)

14:41
09/18/18
09/18
14:41
09/18/18
14:41
Hot Stocks
Nintendo offering Fortnite bundle for Switch »

Nintendo of America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$46.06

-0.26 (-0.56%)

14:40
09/18/18
09/18
14:40
09/18/18
14:40
Hot Stocks
Coca-Cola acquires Australian maker of MOJO Kombucha, terms undisclosed »

The Coca-Cola Company has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SPWR

SunPower

$7.43

0.85 (12.92%)

14:35
09/18/18
09/18
14:35
09/18/18
14:35
Hot Stocks
SunPower spikes higher after receiving solar tariff exclusion »

Shares of solar solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$93.60

-1.77 (-1.86%)

14:35
09/18/18
09/18
14:35
09/18/18
14:35
Options
AbbVie put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIC

SAIC

$77.37

-0.58 (-0.74%)

14:30
09/18/18
09/18
14:30
09/18/18
14:30
Conference/Events
SAIC management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CPA

Copa Holdings

$79.77

-0.23 (-0.29%)

14:29
09/18/18
09/18
14:29
09/18/18
14:29
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$94.29

-1.08 (-1.13%)

14:29
09/18/18
09/18
14:29
09/18/18
14:29
Periodicals
Citron reiterates $60 AbbVie target, says lawsuit 'least of the problems' »

Citron Research just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$6.06

0.07 (1.17%)

14:25
09/18/18
09/18
14:25
09/18/18
14:25
Options
Vipshop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDEN

Golden Entertainment

$26.96

0.51 (1.93%)

14:21
09/18/18
09/18
14:21
09/18/18
14:21
Conference/Events
Golden Entertainment management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/18/18
09/18
14:17
09/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/18/18
09/18
14:16
09/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$96.00

0.63 (0.66%)

14:15
09/18/18
09/18
14:15
09/18/18
14:15
Hot Stocks
California Insurance Commissioner sues AbbVie alleging illegal kickbacks »

California Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.